Abiopharma

OSR HOLDINGS, INC. (OSRH)

Symbol	OSRH
Name	OSR HOLDINGS, INC.
Sector	HEALTH CARE
Region	North America
Industry	Medical/Dental Instruments
Address	10900 NE 4TH STREET,SUITE 2300, BELLEVUE, Washington, 98004, United States
Telephone	+1 425 - 635-7700
Fax	—
Email	—
Website	https://www.osr-holdings.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001840425
Description	OSR is a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. OSR aims to build and develop a robust portfolio of innovative and potentially transformative therapies and healthcare solutions. Its current operating businesses (through three wholly-owned subsidiaries) include (i) developing oral immunotherapies for the treatment of cancer, (ii) developing design-augmented biologics for age-related and other degenerative diseases and (iii) neurovascular intervention medical device and systems distribution in Korea. OSRs vision is to acquire and operate a portfolio of innovative health-care related companies globally. Additional info from NASDAQ: OSR is a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. OSR aims to build and develop a robust portfolio of innovative and potentially transformative therapies and healthcare solutions. Its current operating businesses (through three wholly-owned subsidiaries) include (i) developing oral immunotherapies for the treatment of cancer, (ii) developing design-augmented biologics for age-related and other degenerative diseases and (iii) neurovascular intervention medical device and systems distribution in Korea. OSRs vision is to acquire and operate a portfolio of innovative health-care related companies globally.

2026-06-17 16:27

(99% Neutral) OSR HOLDINGS, INC. (OSRHW) Announces Executive Changes

2026-06-11 17:35

(30% Negative) OSR HOLDINGS, INC. (OSRHW) Announces Development Timeline Update

2026-06-11 14:33

New Form DEFA14A - OSR Holdings, Inc. Filed: 2026-06-11 AccNo: 0001213900-26-067731 Size: 19 KB

2026-06-02 17:16

(99% Neutral) OSR HOLDINGS, INC. (OSRHW) Announces Business Combination

2026-05-26 18:01

New Form DEF 14A - OSR Holdings, Inc. Filed: 2026-05-26 AccNo: 0001213900-26-061078 Size: 4 MB

2026-05-11 10:02

New Form PRE 14A - OSR Holdings, Inc. Filed: 2026-05-11 AccNo: 0001213900-26-054232 Size: 731 KB

2026-05-06 18:26

New Form 8-K/A - OSR Holdings, Inc. Filed: 2026-05-06 AccNo: 0001213900-26-052922 Size: 484 KB Item 9.01: Financial Statements and Exhibits

2026-04-30 17:06

(75% Positive) OSR HOLDINGS, INC. (OSRH) Announces Business Combination

2026-04-22 21:27

(99% Neutral) OSR HOLDINGS, INC. (OSRHW) Announces New Board Appointment

2026-04-22 20:51

New Form SCHEDULE 13G - OSR Holdings, Inc. Filed: 2026-04-22 AccNo: 0002131470-26-000001 Size: 6 KB

No clinical trials found for this company.

No clinical products found for this company.